Novavax COVID-19 Vaccine Alternatives Compared
Novavax COVID-19 Vaccine (sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant) | Paxlovid (nirmatrelvir / ritonavir) | Remdesivir |
|
---|
Novavax COVID-19 Vaccine (sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant) | Paxlovid (nirmatrelvir / ritonavir) | Remdesivir |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for COVID-19. Novavax COVID-19 Vaccine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COVID-19. Paxlovid may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COVID-19. Remdesivir may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about (sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant) | More about Paxlovid (nirmatrelvir / ritonavir) | More about Remdesivir | ||||||||
Ratings & Reviews | ||||||||||
Novavax COVID-19 Vaccine has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Paxlovid has an average rating of 7.1 out of 10 from a total of 531 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 22% reported a negative effect. |
Remdesivir has an average rating of 5.3 out of 10 from a total of 39 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Paxlovid side effects |
View all Remdesivir side effects |
|||||||||
Drug Class | ||||||||||
None |
||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Paxlovid prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
|
|
|
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Veklury | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
N/A |
6.05 hours |
11 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 343 drugs are known to interact with Novavax COVID-19 Vaccine:
|
A total of 690 drugs are known to interact with Paxlovid:
|
A total of 645 drugs are known to interact with Remdesivir:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
N/A |
||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.